ArticleMolecular cancer therapeutics2019

SF2523: Dual PI3K/BRD4 Inhibitor Blocks Tumor Immunosuppression and Promotes Adaptive Immune Responses in Cancer.

Shweta Joshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.